Clinical Observation of Coronary Arterial Microcirculation Dysfunction in Diabetic Patients With Non- Obstructive Coronary Artery Disease
- Conditions
- Complications of Diabetes MellitusCoronary Artery Disease
- Registration Number
- NCT02748980
- Lead Sponsor
- Shaanxi Provincial People's Hospital
- Brief Summary
The purpose of this study is to investigate the prevalence and degree of coronary arterial microcirculaiton dysfunction of non- obstructive coronary artery disease in patients with type 2 diabetes. Furthermore, the risk factors of coronary arterial microcirulation would be screened and identified.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Diagnosis non- obstructive coronary artery disease;
- Positive Treadmill exercise test;
- Positive Cardiac ECT test;
- Positive Holter test
Exclusion Criteria
- Diagnosis of myocardial infarction;
- Diagnosis heart failure;
- Diagnosis of chronic kidney disease;
- Diagnosis of heart valvular disease;
- Diagnosis of malignant tumor;
- Positive heart transplant history;
- Pregnant and lactating women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The coronary microcirculation dysfunction is measured by index of microcirculatory resistance 10 minutes after diagnosis is made by CAG
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie coronary microcirculation dysfunction in type 2 diabetes patients with non-obstructive CAD?
Are there specific biomarkers that correlate with severity of coronary microvascular dysfunction in diabetic non-obstructive CAD?
How does coronary microcirculation dysfunction in non-obstructive CAD compare to obstructive CAD in type 2 diabetes patients?
What are the potential adverse events associated with coronary microcirculation dysfunction in diabetic non-obstructive CAD?
What drug classes show promise in targeting microvascular complications of non-obstructive CAD in type 2 diabetes?
Trial Locations
- Locations (1)
Shaanxi Provincial People's Hospital
🇨🇳Xi'an, Shaanxi, China
Shaanxi Provincial People's Hospital🇨🇳Xi'an, Shaanxi, ChinaNa Zhu, DoctorContact86-29-85251331axemaxme2@sina.com